Related Experiment Video

Updated: May 9, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
10:32

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model

Published on: April 2, 2021

Periocular infantile haemangioma and the role of propranolol

Tanveer Anjum Chaudhry1, Mustafa Kamal, Khabir Ahmad

  • 1Section of Ophthalmology, Department of Surgery, The Aga Khan University, Karachi, Pakistan. tanveer.chaudhry@aku.edu

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
|August 13, 2013
PubMed

Insights

Infantile haemangioma around the eye can cause vision obstruction. Oral propranolol effectively treated a periocular infantile haemangioma in an infant, leading to complete eye opening within 8 months.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Dermatology

Background:

  • Periocular infantile haemangiomas are common benign vascular tumors in infants.
  • These lesions can rapidly proliferate and cause significant complications, including visual axis obstruction.

Observation:

  • A case study of a 4.5-month-old girl with a rapidly growing periocular infantile haemangioma obscuring her left eye's visual axis.

Findings:

  • Oral propranolol therapy, initiated at 1 mg/kg/day and gradually increased, demonstrated an excellent response.
  • Complete resolution of the haemangioma and full eye opening were achieved 8 months post-treatment initiation.

Implications:

  • Propranolol is an effective and safe treatment for periocular infantile haemangiomas.
  • Early intervention with propranolol can prevent long-term visual impairment in infants.

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...